Bioquell has now released their interim results for the year ending 2018. Revenue has increased when compared to the first half of last year as a £173K reduction in US revenue was more than offset by a £723K growth in … Continue reading
Bioquell has now released their final results for the year ended 2017. Revenues increased when compared to last year as a £591K decline in defence sales was more than offset by a £1.9M increase in services sales, a £731K growth … Continue reading
Bioquell has now released their interim results for the year ending 2017. Revenues increased when compared to the first half of last year as an £86K decline in ROW revenue was more than offset by a £1.7M growth in US … Continue reading
Bioquell has now released their final results for the year ended 2016. Revenues declined when compared to last year as a £953K growth in UK revenue and a £301K increase in European revenue was more than offset by a £1.6M … Continue reading
Bioquell has now released its interim results for the year ending 2016. Revenues declined when compared to the first half of last year as a £361K growth in UK revenue was more than offset by a £347K fall in US … Continue reading
Bioquell has now released its final results for the year ended 2015. Revenues declined when compared to last year as a £339K growth in ROW revenue was more than offset by a £409K decrease in European revenues and a £319K … Continue reading
Bioquell has now released its interim results for the year ending 2015. Overall revenues increased modestly when compared to the first half of last year as declines in UK and other European revenue was more than offset by a £1.1M … Continue reading
Bioquell sells biological contamination control services and equipment into the international life sciences, healthcare and defence markets. One important offering is hydrogen peroxide vapour bio-decontamination technology which has been used by the US military programme to eradicate biological warfare agents … Continue reading